1 |
Anti-pseudomonas igy gargle |
- |
- |
- |
- |
299 [1] 299 💬 |
2 |
Behavioral: dyadic psychological support (dps) |
- |
- |
- |
- |
096 [1] 96 💬 |
3 |
Behavioral: neuro-psychological assessment |
- |
- |
- |
- |
240 [1] 240 💬 |
4 |
Boswellia serrata extract ps0201bo capsules |
Indian frankincense |
- |
- |
- |
013 [1] 13 💬 |
5 |
Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
6 |
Cd34+ hscs transduced with the lentivirus vector, vsv-g pseudotyped cl20-4i-ef1a-h?c-opt |
- |
- |
- |
- |
065 [1] 65 💬 |
7 |
Daily ingestion of lactobacillus plantarum ps128 |
Lactobacillus plantarum |
- |
- |
- |
006 [1] 6 💬 |
8 |
Device: scorpio nrg posterior stabilized (ps) |
- |
- |
- |
- |
046 [1] 46 💬 |
9 |
Device: tc-a ps total knee replacement system |
- |
- |
- |
- |
046 [1] 46 💬 |
10 |
Device: tc-plus solution ps total knee replacement system |
- |
- |
- |
- |
046 [1] 46 💬 |
11 |
Device: vanguard 360 tinbn femur with ps bearing |
- |
- |
- |
- |
046 [1] 46 💬 |
12 |
Device: vanguard 360 tinbn femur with psc bearing |
- |
- |
- |
- |
046 [1] 46 💬 |
13 |
Device: vanguard ssk 360 with ps bearing |
- |
- |
- |
- |
046 [1] 46 💬 |
14 |
Device: vanguard ssk 360 with psc bearing |
- |
- |
- |
- |
046 [1] 46 💬 |
15 |
Ex vivo culture and transduction of the patient's autologous cd34+ hsc with lentivirus vector vsv-g pseudotyped cl20- 4i-ef1a-hyc-opt vector |
- |
- |
- |
- |
065 [1] 65 💬 |
16 |
Lactobacillus plantarum ps128 |
Lactobacillus plantarum |
- |
- |
- |
006 [1] 6 💬 |
17 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
18 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
19 |
Other: psp |
- |
- |
- |
- |
013 [1] 13 💬 |
20 |
Posaconazole |
Posaconazole |
[1] D02555 D02555 💬 |
- |
- |
060 [3] 60, 65, 299 💬 |
21 |
Posaconazole (psz) |
Posaconazole |
[1] D02555 D02555 💬 |
- |
- |
065 [1] 65 💬 |
22 |
Probiotic-lactobacillus plantarum ps128 |
Lactobacillus plantarum |
- |
- |
- |
156 [1] 156 💬 |
23 |
Procedure: psychiatric evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
24 |
Ps |
- |
- |
- |
- |
046 [3] 46, 90, 97 💬 |
25 |
Ps-qd |
- |
- |
- |
- |
097 [1] 97 💬 |
26 |
Ps-sp |
- |
- |
- |
- |
097 [1] 97 💬 |
27 |
Ps188 |
- |
- |
- |
- |
113 [1] 113 💬 |
28 |
Ps188 (company code) |
- |
- |
- |
- |
113 [1] 113 💬 |
29 |
Ps220 |
- |
- |
- |
- |
113 [1] 113 💬 |
30 |
Ps524 |
- |
- |
- |
- |
113 [1] 113 💬 |
31 |
Psaer igy |
- |
- |
- |
- |
299 [1] 299 💬 |
32 |
Pseudoephedrine |
Pseudoephedrine |
[4] D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
33 |
Pseudoephedrine + 480 ml water |
Pseudoephedrine |
[5] D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
34 |
Pseudoephedrine + 50 ml water |
Pseudoephedrine |
[5] D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
35 |
Psorcutan-ointment |
- |
- |
- |
- |
036 [1] 36 💬 |
36 |
Psrs11.efs.il2rg.pre* retroviral vector |
- |
- |
- |
- |
065 [1] 65 💬 |
37 |
Psrs11.efs.il2rg.pre* retroviral vector transduce |
- |
- |
- |
- |
065 [1] 65 💬 |
38 |
Psrs11.efs.il2rg.pre* retroviral vector transduced cells |
- |
- |
- |
- |
065 [1] 65 💬 |
39 |
Psyllium |
Plantago seed |
[1] D05525 D05525 💬 |
- |
- |
097 [1] 97 💬 |
40 |
Psyllium husk |
Plantago seed |
[1] D05525 D05525 💬 |
- |
- |
097 [1] 97 💬 |
41 |
Psyllium husk powder |
Plantago seed |
[1] D05525 D05525 💬 |
- |
- |
097 [1] 97 💬 |
42 |
Solu-medrol inj. pso lqf 40mg |
- |
- |
- |
- |
050 [1] 50 💬 |